About this trial
The purpose of this research study is to examine the effects of a 3-month personalized community-based walking program called MyMusiQ. The study uses music cues delivered through a digital device in people with Parkinson disease (PD). The investigators want to know if personalized music cueing through the digital device can improve walking quality, walking ability, daily walking amount and intensity, and quality of life, while helping walking feel more automatic and require less mental effort. Participants will take part in this research study for approximately 18 weeks in total. During this time, participants will complete 4 study visits at designated research centers at Boston University, Washington University in St. Louis, or the University of Utah, depending on the site of enrollment.
Eligibility criteria
Qualifiers
Self-report of diagnosis of typical Parkinson disease determined by a medical doctor
≥ 40 years of age
Community-dwelling (e.g. home, independent living, senior housing)
Have stable PD medications for at least two weeks prior to enrollment
Disqualifiers
< 40 years of age
Diagnosis of atypical Parkinsonism
Modified Hoehn and Yahr stages 4-5
Significantly disturbing freezing episodes during daily walking based on the New Freezing of Gait Questionnaire (Part III Item 7)
Trial design
Treatments tested in this trial
- MR-005 (MedRhythms, Inc., Portland, ME)
Treatment groups
Sponsors and collaborators
Boston University Charles River Campus
Lead sponsor
Michael J. Fox Foundation for Parkinson's Research
Collaborator
University of Utah
Collaborator
Washington University School of Medicine
Collaborator